vimarsana.com

Latest Breaking News On - Infinity pharmaceuticals - Page 14 : vimarsana.com

Faron Pharmaceuticals Announces Board Changes

TURKU, Finland and BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage.

North marketUnited statesUppsala lanChristopher goldenJenniferc smith parkerBristol myers squibbJuha karttunenSensei biotherapeuticsChristine ann rothLytix biopharmaJo turnerChristine rothFrank armstrongSandy jamiesonVividion therapeutics incAmerican society of clinical oncology

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors .

Brian schallLos angelesFirmbrian schallSchall law firmSecurities exchangeInfinity pharmaceuticals incPharma incExchange commissionNews networkInfinity pharmaceuticalsSecurities exchange actPark eastAttorney advertisingSchall law firmbrianSchall law

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI)..

New yorkUnited statesFrance generalCity ofUnited kingdomTel avivMadeline perkinsRoberts willoughbyLos angelesAbrahaml pomerantzInfinity pharmaceuticals incPrnewswire pomerantzPharma incInfinity pharmaceuticalsChief executive officer adeline perkinsPomerantz llp

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Infinity Pharmaceuticals, Inc Investors to Secure Counsel Before Important Deadline in Securities Class Action

/PRNewswire/ WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI).

New yorkUnited statesLaurence rosenPhillip kimSecurities class action servicesChinese companyRosen law firmPharma incInfinity pharmaceuticals incInfinity pharmaceuticalsClass periodLaw firmClass action servicesDefendant perkinsClass has beenThe rosen law firm

Bragar Eagel & Squire, P C Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm - Comerica (NYSE:CMA), Shift4 Payments (NYSE:FOUR)

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of

United statesNew yorkSouth carolinaMarion passmoreBrandon walkerBragar eagel squirePayments incComerica incorporatedInfinity pharmaceuticals incInfinity pharmaceuticalsPlaintiff deadlineClass periodDirect expressFederal contractBragar eagel

vimarsana © 2020. All Rights Reserved.